This Morning's Ruth Langsford shares rare photo of herself whilst pregnant with son Jack
June 13, 2020 - 10:15 BST Andrea Caamano Ruth Langsford treated fans to a never-before-seen picture of herself taken 19 years ago, just a day after she found out that her and Eamonn were expecting their first child together.
Taking to Instagram on Saturday morning, the presenter wrote:"Sorting through some old photos and found this ...19 years ago at my godson Charlie's christening. The day before I had just found out I was pregnant with Jack!"@eamonnholmes was away with the children so my best friend here @balshaw.sam was the first to know...a very special moment together. We've shared a lot of those during our 30-year friendship...thanks mate.
Fans were delighted with the snap, praising Ruth for her timeless look:"You have not changed at all, still got your lovely figure and smile."A second follower wrote:"Lovely photo..you still look exactly the same..x." Ruth was thankful for all the compliments, replying:"Hmmm...but thank you!! Wish I still had slim legs like that! X." She even cheekily told another one to"go to Specsavers" after they had commented that she hasn't changed a bit.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How Eamonn Holmes supported Ruth Langsford through devastating family tragedyThis Morning host Ruth Langsford had 'no desire' to be in the public eye after the tragedy, but devoted husband Eamonn Holmes comforted his grieving wife
Read more »
Good Morning Britain's Charlotte Hawkins shares rare snap of lookalike daughterElla Rose and the newsreader were seen giggling together giggling as Charlotte held a multi-coloured cupcake which her daughter designed
Read more »
Hayden Panettiere Shares Rare Photos of 5-Year-Old DaughterThe actress has made some of her private family photos public on the social media platform.
Read more »
Shares of Apellis rise on clinical data for rare blood disease drugShares of Apellis Pharmaceuticals Inc. gained 5.1% in premarket trading on Friday after it shared details from a late-stage clinical trial evaluating its experimental drug pegcetacoplan against Alexion Pharmaceuticals Inc.'s Soliris as a treatment for paroxysmal nocturnal hemoglobinuria. The study found that pegcetacoplan was better than Soliris in improving hemoglobin levels in adults with the rare blood disease. Soliris brought in $3.9 billion in revenue in 2019. Apellis said it plans to submit a new drug application for pegcetacoplan to the Food and Drug Administration in the second half of the year. Its stock is down 0.5% year-to-date, while the S&P 500 has declined 7.1%.
Read more »